Results 171 to 180 of about 927,791 (328)
Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy
Early cardiac biomarker monitoring in AML induction therapy showed significantly higher hsTnT levels after daunorubicin 90 mg/m2 compared with 60 mg/m2, indicating a dose‐dependent early myocardial effect. ABSTRACT Anthracyclines are an essential component of induction therapy for acute myeloid leukemia (AML), but their optimal dosing and the ...
Stefan Markus Dendorfer +44 more
wiley +1 more source
Reaffirming DEI as a central value of JCM
Romney M. Humphries, Alexander J. McAdam
doaj +1 more source
Notes regarding the next era for the <i>Journal of Clinical Microbiology</i>. [PDF]
Humphries RM.
europepmc +1 more source
Current Status of Matrix-Assisted Laser Desorption/Ionization–Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in Clinical Diagnostic Microbiology [PDF]
Sachio Tsuchida +2 more
openalex +1 more source
Acute Exercise Challenge and Airway Dynamics in Youth With Sickle Cell Anemia: A Multicenter Study
Changes in airway dynamics in children with sickle cell anemia after maximal cardiopulmonary exercise testing and a controlled intensity interval excercise challenge. ABSTRACT Sickle cell anemia (SCA) leads to reduced physical functioning and cardiopulmonary fitness. Prior studies suggest that airway hyperresponsiveness to bronchoprovocation testing is
Robyn T. Cohen +9 more
wiley +1 more source
Commentary: Individualized Quality Control Plan (IQCP): Is It Value-Added for Clinical Microbiology? [PDF]
Susan E. Sharp +2 more
openalex +1 more source
ABSTRACT The COMMANDS trial established luspatercept as a first‐line treatment for anemia in transfusion‐dependent lower‐risk (LR) myelodysplastic syndromes (MDS). Here we report red blood cell (RBC) transfusion response analysis based on somatic mutations profile and disease risk for patients treated with luspatercept or epoetin alfa in the COMMANDS ...
Rami S. Komrokji +9 more
wiley +1 more source
Perspectives in clinical microbiology for combating multi-drug resistant bacterial infections. [PDF]
de Oliveira AM, de Castro CP.
europepmc +1 more source

